|Bid||1,416.80 x 0|
|Ask||1,417.20 x 0|
|Day's Range||1,400.60 - 1,419.00|
|52 Week Range||1,190.80 - 1,528.80|
|Beta (5Y Monthly)||0.38|
|PE Ratio (TTM)||16.35|
|Earnings Date||Oct 27, 2021|
|Forward Dividend & Yield||0.80 (5.76%)|
|Ex-Dividend Date||Aug 19, 2021|
|1y Target Est||N/A|
Both prosecutors and defense attorneys elicited crucial points during their examination of the government’s first three witnesses in the criminal fraud case now underway against former Theranos founder and CEO Elizabeth Holmes.
Suzanne Judd, Ph.D., Epidemiologist at the University of Alabama at Birmingham School of Public Health, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Glaxo (GSK) is seeking approval of Nucala for hypereosinophilic syndrome, eosinophilic granulomatosis with polyangiitis) and chronic rhinosinusitis with nasal polyps in Europe